US Stock MarketDetailed Quotes

BCTX BriaCell Therapeutics

Watchlist
  • 0.770
  • -0.024-3.07%
Close Nov 4 16:00 ET
  • 0.770
  • 0.0000.00%
Post 19:59 ET
27.86MMarket Cap-2655P/E (TTM)

BriaCell Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1.61%-24.13M
63.04%-4.04M
4.65%-5.08M
-87.29%-7.4M
-114.69%-7.61M
-90.20%-23.74M
-228.32%-10.92M
-10.53%-5.33M
-54.59%-3.95M
-99.17%-3.54M
Net income from continuing operations
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
4.61%-11.33M
638.51%5.96M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
Operating gains losses
-1,227.46%-28.14M
11.01%-4.53M
-1,922.27%-10.91M
-79.21%1.59M
-246.84%-14.28M
-118.18%-2.12M
-7.73%-5.09M
-109.10%-539.43K
151.56%7.63M
-116.31%-4.12M
Depreciation and amortization
449.39%83.9K
1,797.43%72.44K
-0.05%3.82K
0.05%3.82K
0.00%3.82K
-0.01%15.27K
-0.03%3.82K
0.03%3.82K
-0.05%3.82K
0.03%3.82K
Change In working capital
299.70%7.05M
132.79%1.29M
2,154.47%3.74M
6,070.75%1.84M
-68.15%180.33K
-802.65%-3.53M
-507.17%-3.95M
88.66%-181.88K
-88.77%29.86K
2,664.38%566.19K
-Change in receivables
-14,107.23%-732.58K
-18,411.89%-736.22K
349.87%14.91K
-142.06%-8.74K
54.66%-2.54K
145.36%5.23K
58.45%-3.98K
-147.24%-5.97K
365.02%20.77K
17.17%-5.6K
-Change in prepaid assets
148.35%2.13M
130.43%1.33M
199.96%888.22K
-428.26%-1.03M
74.05%937.82K
-475.56%-4.4M
-1,179.51%-4.36M
35.52%-888.59K
212.99%312.73K
389.37%538.82K
-Change in payables and accrued expense
557.82%5.66M
68.13%703.4K
297.57%2.83M
1,047.78%2.88M
-2,390.30%-754.95K
123.88%860.37K
-27.22%418.36K
398.37%712.68K
-274.72%-303.64K
126.28%32.96K
Cash from discontinued investing activities
Operating cash flow
-1.61%-24.13M
63.04%-4.04M
4.65%-5.08M
-87.29%-7.4M
-114.69%-7.61M
-90.20%-23.74M
-228.32%-10.92M
-10.53%-5.33M
-54.59%-3.95M
-99.17%-3.54M
Investing cash flow
Cash flow from continuing investing activities
-681.8K
-456.8K
-225K
0
0
0
Net PPE purchase and sale
---456.8K
----
----
----
----
--0
----
----
----
----
Net business purchase and sale
---225K
--0
---225K
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
---681.8K
---456.8K
---225K
----
----
--0
--0
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
11.75%4.42M
10.47%4.42M
0
0
0
205.65%3.95M
2,603.40%4M
-99.88%1.59K
0
-47.29K
Net common stock issuance
11.79%4.42M
10.47%4.42M
--0
--0
--0
138.86%3.95M
3,996.09%4M
--0
--0
---47.29K
Proceeds from stock option exercised by employees
--0
--0
----
----
----
-99.98%1.59K
--0
----
----
----
Cash from discontinued financing activities
Financing cash flow
11.75%4.42M
10.47%4.42M
--0
--0
--0
205.65%3.95M
2,603.40%4M
-99.88%1.59K
--0
---47.29K
Net cash flow
Beginning cash position
-48.22%21.25M
-96.68%935.69K
-81.36%6.24M
-63.56%13.65M
-48.22%21.25M
-28.33%41.04M
-36.74%28.17M
-30.18%33.5M
-32.51%37.45M
-28.33%41.04M
Current changes in cash
-3.02%-20.39M
98.94%-73.61K
0.40%-5.31M
-87.29%-7.4M
-111.86%-7.61M
-21.96%-19.79M
-98.51%-6.92M
-54.29%-5.33M
47.37%-3.95M
-101.83%-3.59M
End cash Position
-95.94%862.09K
-95.94%862.09K
-96.68%935.69K
-81.36%6.24M
-63.56%13.65M
-48.22%21.25M
-48.22%21.25M
-36.74%28.17M
-30.18%33.5M
-32.51%37.45M
Free cash flow
-3.53%-24.58M
58.86%-4.49M
4.65%-5.08M
-87.29%-7.4M
-114.69%-7.61M
-90.20%-23.74M
-228.32%-10.92M
-10.53%-5.33M
-54.59%-3.95M
-99.17%-3.54M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023(Q1)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1.61%-24.13M63.04%-4.04M4.65%-5.08M-87.29%-7.4M-114.69%-7.61M-90.20%-23.74M-228.32%-10.92M-10.53%-5.33M-54.59%-3.95M-99.17%-3.54M
Net income from continuing operations 75.71%-4.93M48.37%-1.25M134.57%1.69M4.61%-11.33M638.51%5.96M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M
Operating gains losses -1,227.46%-28.14M11.01%-4.53M-1,922.27%-10.91M-79.21%1.59M-246.84%-14.28M-118.18%-2.12M-7.73%-5.09M-109.10%-539.43K151.56%7.63M-116.31%-4.12M
Depreciation and amortization 449.39%83.9K1,797.43%72.44K-0.05%3.82K0.05%3.82K0.00%3.82K-0.01%15.27K-0.03%3.82K0.03%3.82K-0.05%3.82K0.03%3.82K
Change In working capital 299.70%7.05M132.79%1.29M2,154.47%3.74M6,070.75%1.84M-68.15%180.33K-802.65%-3.53M-507.17%-3.95M88.66%-181.88K-88.77%29.86K2,664.38%566.19K
-Change in receivables -14,107.23%-732.58K-18,411.89%-736.22K349.87%14.91K-142.06%-8.74K54.66%-2.54K145.36%5.23K58.45%-3.98K-147.24%-5.97K365.02%20.77K17.17%-5.6K
-Change in prepaid assets 148.35%2.13M130.43%1.33M199.96%888.22K-428.26%-1.03M74.05%937.82K-475.56%-4.4M-1,179.51%-4.36M35.52%-888.59K212.99%312.73K389.37%538.82K
-Change in payables and accrued expense 557.82%5.66M68.13%703.4K297.57%2.83M1,047.78%2.88M-2,390.30%-754.95K123.88%860.37K-27.22%418.36K398.37%712.68K-274.72%-303.64K126.28%32.96K
Cash from discontinued investing activities
Operating cash flow -1.61%-24.13M63.04%-4.04M4.65%-5.08M-87.29%-7.4M-114.69%-7.61M-90.20%-23.74M-228.32%-10.92M-10.53%-5.33M-54.59%-3.95M-99.17%-3.54M
Investing cash flow
Cash flow from continuing investing activities -681.8K-456.8K-225K000
Net PPE purchase and sale ---456.8K------------------0----------------
Net business purchase and sale ---225K--0---225K----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow ---681.8K---456.8K---225K----------0--0--0--------
Financing cash flow
Cash flow from continuing financing activities 11.75%4.42M10.47%4.42M000205.65%3.95M2,603.40%4M-99.88%1.59K0-47.29K
Net common stock issuance 11.79%4.42M10.47%4.42M--0--0--0138.86%3.95M3,996.09%4M--0--0---47.29K
Proceeds from stock option exercised by employees --0--0-------------99.98%1.59K--0------------
Cash from discontinued financing activities
Financing cash flow 11.75%4.42M10.47%4.42M--0--0--0205.65%3.95M2,603.40%4M-99.88%1.59K--0---47.29K
Net cash flow
Beginning cash position -48.22%21.25M-96.68%935.69K-81.36%6.24M-63.56%13.65M-48.22%21.25M-28.33%41.04M-36.74%28.17M-30.18%33.5M-32.51%37.45M-28.33%41.04M
Current changes in cash -3.02%-20.39M98.94%-73.61K0.40%-5.31M-87.29%-7.4M-111.86%-7.61M-21.96%-19.79M-98.51%-6.92M-54.29%-5.33M47.37%-3.95M-101.83%-3.59M
End cash Position -95.94%862.09K-95.94%862.09K-96.68%935.69K-81.36%6.24M-63.56%13.65M-48.22%21.25M-48.22%21.25M-36.74%28.17M-30.18%33.5M-32.51%37.45M
Free cash flow -3.53%-24.58M58.86%-4.49M4.65%-5.08M-87.29%-7.4M-114.69%-7.61M-90.20%-23.74M-228.32%-10.92M-10.53%-5.33M-54.59%-3.95M-99.17%-3.54M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data